Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice

Journal of Physiology and Biochemistry

Volumn 72, Issue 2, 2016, Pages 269-280

  Naowaboot, Jarinyaporn ^a   Wannasiri, Supaporn ^a   Pannangpetch, Patchareewan ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Inflammation; Insulin resistance; Morin; Obesity; Oxidative stress

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; CARNITINE PALMITOYLTRANSFERASE 1A; CARNITINE PALMITOYLTRANSFERASE I; CATALASE; FAT DROPLET; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; INTERLEUKIN 6; LEPTIN; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MORIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; FLAVONOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; HISTOPATHOLOGY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ADVERSE EFFECTS; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID PEROXIDATION; LIVER; METABOLISM; PATHOLOGY; WEIGHT GAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-OBESITY AGENTS; ANTIOXIDANTS; BIOMARKERS; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIPID PEROXIDATION; LIPOGENESIS; LIVER; MALE; MICE, INBRED ICR; OBESITY; OXIDATIVE STRESS; WEIGHT GAIN;

EID: 84961112404     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-016-0477-5     Document Type: Article

References (46)

1. Andreeva-Gateva P, Popova D, Orbetsova V (2001) Antioxidant parameters in metabolic syndrome–a dynamic evaluation during oral glucose tolerance test. Vutr Boles 33(2–3):48–53
2. Assini JM, Mulvihill EE, Burke AC, Sutherland BG, Telford DE, Chhoker SS, Sawyez CG, Drangova M, Adams AC, Kharitonenkov A, Pin CL, Huff MW (2015) Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21. Endocrinology 156(6):2087–2102
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
4. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114(2):147–152
5. Cao R, Cronk ZX, Zha W, Sun L, Wang X, Fang Y, Studer E, Zhou H, Pandak WM, Dent P, Gil G, Hylemon PB (2010) Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway. J Lipid Res 51(8):2234–2244
6. Carmiel-Haggai M, Cederbaum AI, Nieto N (2005) A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 19(1):136–138
7. Demircan N, Gurel A, Armutcu F, Unalacak M, Aktunc E, Atmaca H (2008) The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Med Sci Monit 14(2):CR97–101
8. Enriori PJ, Evans AE, Sinnayah P, Cowley MA (2006) Leptin resistance and obesity. Obesity (Silver Spring) 14(Suppl 5):254S–258S
9. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114(12):1752–1761
10. Heeba GH, Mahmoud ME (2014) Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B. Environ Toxicol Pharmacol 37(2):662–671
11. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87–91
12. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288(2):E454–461
13. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439–451
14. Kapoor R, Kakkar P (2012) Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. Plos One 7(8):e41663
15. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C (2000) Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 26(5):387–392
16. Kim JM, Lee EK, Park G, Kim MK, Yokozawa T, Yu BP, Chung HY (2010) Morin modulates the oxidative stress-induced NF-kappaB pathway through its anti-oxidant activity. Free Radic Res 44(4):454–461
17. Kwon EY, Jung UJ, Park T, Yun JW, Choi MS (2015) Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes 64(5):1658–1669
18. Lee JS, Kim KJ, Kim YH, Kim DB, Shin GH, Cho JH, Kim BK, Lee BY, Lee OH (2014) Codonopsis lanceolata extract prevents diet-induced obesity in C57BL/6 mice. Nutrients 6(11):4663–4677
19. Lee YH, Magkos F, Mantzoros CS, Kang ES (2011) Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism 60(12):1664–1672
20. Lopez-Soldado I, Zafra D, Duran J, Adrover A, Calbo J, Guinovart JJ (2015) Liver glycogen reduces food intake and attenuates obesity in a high-fat diet-fed mouse model. Diabetes 64(3):796–807
21. Naowaboot J, Somparn N, Saentaweesuk S, Pannangpetch P (2015) Umbelliferone improves an impaired glucose and lipid metabolism in high-fat diet/streptozotocin-induced type 2 diabetic rats. Phytother Res 29:1388–1395
22. Oakes ND, Thalen PG, Jacinto SM, Ljung B (2001) Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes 50(5):1158–1165
23. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7(6):496–507
24. Ola MS, Aleisa AM, Al-Rejaie SS, Abuohashish HM, Parmar MY, Alhomida AS, Ahmed MM (2014) Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci 35:1003–1008
25. Pajvani UB, Scherer PE (2003) Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 3(3):207–213
26. Patel C, Ghanim H, Ravishankar S, Sia CL, Viswanathan P, Mohanty P, Dandona P (2007) Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab 92(11):4476–4479
27. Pawlowska AM, Oleszek W, Braca A (2008) Quali-quantitative analyses of flavonoids of Morus nigra L. and Morus alba L. (Moraceae) fruits. J Agric Food Chem 56(9):3377–3380
28. Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118(3):829–838
29. Prasad A, Quyyumi AA (2004) Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 110(11):1507–1512
30. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148(5):852–871
31. Shimomura I, Bashmakov Y, Horton JD (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274(42):30028–30032
32. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6(1):77–86
33. Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequences of fatty liver. Endocr Rev 29(7):939–960
34. Sung YY, Kim DS, Choi G, Kim SH, Kim HK (2014) Dohaekseunggi-tang extract inhibits obesity, hyperlipidemia, and hypertension in high-fat diet-induced obese mice. BMC Complement Altern Med 14:372
35. Torra IP, Chinetti G, Duval C, Fruchart JC, Staels B (2001) Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice. Curr Opin Lipidol 12(3):245–254
36. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB (1998) Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273(47):31615–31620
37. Valera A, Pujol A, Pelegrin M, Bosch F (1994) Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 91(19):9151–9154
38. Vanitha P, Uma C, Suganya N, Bhakkiyalakshmi E, Suriyanarayanan S, Gunasekaran P, Sivasubramanian S, Ramkumar KM (2014) Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and beta-cell function in streptozotocin-induced diabetic rats. Environ Toxicol Pharmacol 37(1):326–335
39. Vinayagam R, Xu B (2015) Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab (Lond) 12:60
40. Wang X, Zhang DM, Gu TT, Ding XQ, Fan CY, Zhu Q, Shi YW, Hong Y, Kong LD (2013) Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. Biochem Pharmacol 86(12):1791–1804
41. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796–1808
42. Wijeratne SS, Abou-Zaid MM, Shahidi F (2006) Antioxidant polyphenols in almond and its coproducts. J Agric Food Chem 54(2):312–318
43. Xiao N, Mei F, Sun Y, Pan G, Liu B, Liu K (2014) Quercetin, luteolin, and epigallocatechin gallate promote glucose disposal in adipocytes with regulation of AMP-activated kinase and/or sirtuin 1 activity. Planta Med 80(12):993–1000
44. Xu M, Hu J, Zhao W, Gao X, Jiang C, Liu K, Liu B, Huang F (2014) Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes. Mol Nutr Food Res 58(5):931–941
45. Yu Y, Wu Y, Szabo A, Wu Z, Wang H, Li D, Huang XF (2013) Teasaponin reduces inflammation and central leptin resistance in diet-induced obese male mice. Endocrinology 154(9):3130–3140
46. Zhang R, Kang KA, Piao MJ, Maeng YH, Lee KH, Chang WY, You HJ, Kim JS, Kang SS, Hyun JW (2009) Cellular protection of morin against the oxidative stress induced by hydrogen peroxide. Chem Biol Interact 177(1):21–27